SCHEMBL6598093

SCHEMBL6598093

CC(C)(C)N1CCN(C(=O)c2ccc(Br)o2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.54
ALDH1A1 P00352 6/20 0.53
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
POLB P06746 1/20 0.52
CHRNB2 P17787 4/20 0.50
CHRNB4 P30926 4/20 0.50
CHRNA3 P32297 4/20 0.50
CHRNA4 P43681 4/20 0.50
LMNA P02545 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
MAPT P10636 2/20 0.48
KDM4E B2RXH2 1/20 0.48
CHRNA7 P36544 2/20 0.45
NPC1 O15118 1/20 0.45
PKM P14618 1/20 0.45
RAB9A P51151 1/20 0.45
TP53 P04637 1/20 0.44
ALOX15 P16050 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1771402 0.83 KMT2A (0.59) TSHRALDH1A1KMT2AMEN1POLB
SCHEMBL6034789 0.81 SETD7 (0.59) TSHRALDH1A1KMT2AMEN1POLB
SCHEMBL6035071 0.81 TSHR (0.59) TSHRALDH1A1KMT2AMEN1POLB
SCHEMBL3153541 0.80 TSHR (0.58) TSHRALDH1A1KMT2AMEN1POLB
SCHEMBL3150435 0.78 ALDH1A1 (0.59) TSHRALDH1A1KMT2AMEN1POLB
SCHEMBL6599669 0.76 CHRNB2 (0.61) TSHRALDH1A1KMT2AMEN1POLB
SCHEMBL27506976 0.76 TSHR (0.55) TSHRALDH1A1KMT2AMEN1POLB
Hydrochloric Acid SCHEMBL1763285 0.75 CHRNB2 (0.60) TSHRALDH1A1KMT2AMEN1POLB
SCHEMBL2673282 0.75 TSHR (0.67) TSHRALDH1A1KMT2AMEN1POLB
Ethylene SCHEMBL8379882 0.74 TSHR (0.52) TSHRALDH1A1KMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1414801-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 AstraZeneca AB (SE) 2004-05-06 EP disclosed
WO-2003004472-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 ASTRAZENECA AB (SE) 2003-01-16 WO disclosed